Chronic Obstructive Pulmonary Disease (COPD) and Advance Directives
DIABPCO
1 other identifier
observational
525
1 country
1
Brief Summary
The aim of this study is to evaluate if the participation of COPD patients to a workshop on advance directives increases the number of patients who write them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 16, 2019
CompletedFirst Submitted
Initial submission to the registry
July 1, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2020
CompletedSeptember 19, 2024
February 1, 2021
1.5 years
July 1, 2020
September 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patient who write their advance directives
The Primary Outcome Measure is the collect of the number of patients who write their advance directives after their participation of the health workshop
At the end of patient hospital stay, approximately 6 weeks
Secondary Outcomes (1)
Measure of patient's satisfaction
At the end of patient hospital stay, approximately 6 weeks
Interventions
A workshop will take place during the third week of patient care to inform them about COPD, exacerbations, prognostic and advance directives. Then, a personal interview with patients who have participated to this workshop will take place at the end of their hospital stay, to collect their advance directives and their degree of satisfaction about this process.
Eligibility Criteria
Patient with COPD Gold 3 or 4 who accept to participate to the workshop
You may qualify if:
- COPD Gold 3 or 4 and Curtis criteria
You may not qualify if:
- left to the discretion of the investigator if he finds that it will not be beneficial for the patient : for example if the workshop is judged to be at risk of being anxiety-provoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hôpital NOVOlead
Study Sites (1)
Les Cèdres SSR Pneumologie / Réhabilitation Respiratoire
Aincourt, 95510, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-François Boitiaux
Hôpital NOVO
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2020
First Posted
July 7, 2020
Study Start
May 16, 2019
Primary Completion
October 31, 2020
Study Completion
October 31, 2020
Last Updated
September 19, 2024
Record last verified: 2021-02